These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38655005)

  • 1. Early identification of SOX17 deficiency in infants to guide management of heritable pulmonary arterial hypertension using PDA stent to create reverse Potts shunt physiology.
    Ostler H; Fall C; El-Said H; Justino H; Haldeman S; Carroll J; Rao R
    Pulm Circ; 2024 Apr; 14(2):e12366. PubMed ID: 38655005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies.
    Latus H; Apitz C; Moysich A; Kerst G; Jux C; Bauer J; Schranz D
    J Heart Lung Transplant; 2014 May; 33(5):542-6. PubMed ID: 24630407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
    Best DH; Sumner KL; Smith BP; Damjanovich-Colmenares K; Nakayama I; Brown LM; Ha Y; Paul E; Morris A; Jama MA; Dodson MW; Bayrak-Toydemir P; Elliott CG
    Chest; 2017 Apr; 151(4):821-828. PubMed ID: 27884767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognosis analysis of idiopathic and hereditary pulmonary hypertension patients with
    Zhang X; Zhang C; Li Q; Piao C; Zhang H; Gu H
    Pulm Circ; 2021; 11(4):20458940211044577. PubMed ID: 34966542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
    Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potts shunt as an effective palliation for patients with end stage pulmonary arterial hypertension.
    Bobhate P; Mohanty SR; Tailor K; Kadam S; Karande T; Bhavsar K; Katanna HB; Rao S; Kulkarni S
    Indian Heart J; 2021; 73(2):196-204. PubMed ID: 33865518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of genetics in pulmonary arterial hypertension.
    Ma L; Chung WK
    J Pathol; 2017 Jan; 241(2):273-280. PubMed ID: 27770446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case series of transcatheter Potts Shunt creation in a pediatric population affected with refractory pulmonary artery hypertension: focus on the role of ECMO.
    Mirabile C; Malekzadeh-Milani S; Bojan M; Raisky O; Gaudin R; Bonnet D; Boudjemline Y
    Perfusion; 2021 May; 36(4):415-420. PubMed ID: 32880213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional creation of an endogenous reverse Potts shunt in an infant with pulmonary hypertension and genetic surfactant disorder-a case report.
    Sallmon H; Berger F; Weber SC; Fischer HS; Hansmann G; Opgen-Rhein B
    Cardiovasc Diagn Ther; 2020 Oct; 10(5):1696-1700. PubMed ID: 33224783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
    Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treprostinil Effectiveness in Higher-Risk Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension.
    He Y; Li Q; Zhang C; Keller BB; Gu H
    Can J Cardiol; 2024 Apr; 40(4):613-621. PubMed ID: 37944814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and Other Omics in Pediatric Pulmonary Arterial Hypertension.
    Welch CL; Chung WK
    Chest; 2020 May; 157(5):1287-1295. PubMed ID: 32006592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.
    Austin ED; Menon S; Hemnes AR; Robinson LR; Talati M; Fox KL; Cogan JD; Hamid R; Hedges LK; Robbins I; Lane K; Newman JH; Loyd JE; West J
    Pulm Circ; 2011; 1(3):389-98. PubMed ID: 22140629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect.
    Capel A; Lévy M; Szezepanski I; Malekzadeh-Milani S; Vouhé P; Bonnet D
    ESC Heart Fail; 2021 Feb; 8(1):326-332. PubMed ID: 33216469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and genomics of pulmonary arterial hypertension.
    Machado RD; Eickelberg O; Elliott CG; Geraci MW; Hanaoka M; Loyd JE; Newman JH; Phillips JA; Soubrier F; Trembath RC; Chung WK
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S32-S42. PubMed ID: 19555857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.
    Zhu N; Gonzaga-Jauregui C; Welch CL; Ma L; Qi H; King AK; Krishnan U; Rosenzweig EB; Ivy DD; Austin ED; Hamid R; Nichols WC; Pauciulo MW; Lutz KA; Sawle A; Reid JG; Overton JD; Baras A; Dewey F; Shen Y; Chung WK
    Circ Genom Precis Med; 2018 Apr; 11(4):e001887. PubMed ID: 29631995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.
    Welch CL; Austin ED; Chung WK
    Pediatr Pulmonol; 2021 Mar; 56(3):614-620. PubMed ID: 31917901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients.
    Baruteau AE; Belli E; Boudjemline Y; Laux D; Lévy M; Simonneau G; Carotti A; Humbert M; Bonnet D
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):e105-10. PubMed ID: 25475943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
    Welch CL; Aldred MA; Balachandar S; Dooijes D; Eichstaedt CA; Gräf S; Houweling AC; Machado RD; Pandya D; Prapa M; Shaukat M; Southgate L; Tenorio-Castano J; ; Chung WK;
    Genet Med; 2023 Nov; 25(11):100925. PubMed ID: 37422716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analyses in a cohort of 191 pulmonary arterial hypertension patients.
    Yang H; Zeng Q; Ma Y; Liu B; Chen Q; Li W; Xiong C; Zhou Z
    Respir Res; 2018 May; 19(1):87. PubMed ID: 29743074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.